Alzheimer’s Disease & Dementia, author_name|Malak Saleh, Brain & Nervous System Disorders, Disease & Medical Conditions, Government, health, Health Care Industry, language|en-US, Pharmaceuticals & Drug Trials, provider_name|Engadget, region|US, site|engadget, Tech Industry, Tech News
The first drug that slows Alzheimer’s has finally received FDA approval
Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the…
